Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-12

Clinical Trial Update: Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1) [Phase 1]

View source ↗

Summary

Phase 1 PREPARE 1 trial reports the tolerability of a ketamine dose for postpartum depression and postoperative pain following cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Grace Lim, MD, MS | Conditions: Pain, Postoperative, Depression, Postpartum | Phase 1 | Status: COMPLETED | Results posted: 2025-09-12